Kobayashi T, Motoya S, Nakamura S, Yamamoto T, et al. Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol 2021 Apr 19. pii: S2468-1253(21)00062.
PMID: 33887262